Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Diffusion Tensor Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 4 Breast Neoplasms 4 Brain Neoplasms 4 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Vision Disorders 1 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pituitary Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuritis 1 Neoplasm Metastasis 1 Medulloblastoma 1 Mediastinal Neoplasms 1 Lymphedema 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Familial ependymoma 1 Esthesioneuroblastoma, Olfactory 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Cisplatin 146 Radiotherapy 69 Brachytherapy 63 Paclitaxel 61 Carboplatin 59 pembrolizumab 54 Bevacizumab 34 Colposcopy 27 Gemcitabine 26 Surveys and Questionnaires 24 Radiation 23 Topotecan 22 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 22 human papillomavirus vaccine, L1 type 16, 18 19 Papillomavirus Vaccines 19 Nivolumab 18 Magnetic Resonance Spectroscopy 18 Blood Specimen Collection 17 Platinum 16 Drug Therapy 16 Biopsy 16 Radiotherapy, Intensity-Modulated 15 Cyclophosphamide 15 Docetaxel 14 atezolizumab 13 Papanicolaou Test 13 fludarabine 12 Vaccines 12 Taxes 12 Methods 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01060033 2017-04-14

MRI

Washington University School of Medicine

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡